XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements
 3 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
In accordance with the authoritative guidance on fair value measurements and disclosure under GAAP, the Company determines fair value using a fair value hierarchy that distinguishes between market participant assumptions developed based on market data obtained from sources independent of the reporting entity, and the reporting entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances and expands disclosure about fair value measurements.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date, essentially the exit price.
The levels of fair value hierarchy are:
Level 1: Quoted prices in active markets for identical assets and liabilities at the measurement date that the Company has the ability to access.
Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3: Unobservable inputs for which there is little or no market data available. These inputs reflect management's assumptions of what market participants would use in pricing the asset or liability.
Level 1 investments are valued based on quoted market prices in active markets and include the Company's cash equivalent investments. Level 2 investments, which include investments that are valued based on quoted prices in markets that are not active, broker or dealer quotations, actual trade data, benchmark yields or alternative pricing sources with reasonable levels of price transparency, include the Company's certificates of deposit, corporate bonds and notes, municipal bonds and notes, U.S. government securities, U.S. government agency securities and international government securities. Fair values for the Company's level 2 investments are based on similar assets without applying significant judgments. In addition, all of the Company's level 2 investments have a sufficient level of trading volume to demonstrate that the fair values used are appropriate for these investments.
A financial instrument's level within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes "observable" requires significant judgment by the Company. The Company considers observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
The Company's financial assets measured at fair value on a recurring basis subject to the disclosure requirements at December 31, 2021, were as follows (in thousands):
 
 Fair Value Measurements at Reporting Date Using 
 Quoted Prices in Active Markets for Identical Securities
(Level 1)		Significant Other 
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Fair Value at
December 31,
2021
Cash equivalents$19,265 $779 $— $20,044 
Short-term investments
Available-for-sale securities — certificates of deposits— 992 — 992 
Available-for-sale securities — corporate bonds and notes— 177,093 — 177,093 
Available-for-sale securities — municipal bonds and notes— 15,359 — 15,359 
Available-for-sale securities — U.S. government securities— 135,934 — 135,934 
Available-for-sale securities — U.S. government agency securities
— 17,170 — 17,170 
Long-term investments
Available-for-sale securities — corporate bonds and notes— 48,638 — 48,638 
Available-for-sale securities — municipal bonds and notes— 2,239 — 2,239 
Available-for-sale securities — U.S. government securities— 24,341 — 24,341 
Available-for-sale securities — U.S. government agency securities
— 1,773 — 1,773 
Total$19,265 $424,318 $— $443,583 
The Company's financial assets measured at fair value on a recurring basis subject to the disclosure requirements at September 30, 2021, were as follows (in thousands):
 
 Fair Value Measurements at Reporting Date Using 
 Quoted Prices in Active Markets 
for Identical Securities
(Level 1)		Significant
Other 
Observable Inputs
(Level 2)		Significant
Unobservable
Inputs
(Level 3)		Fair Value at
September 30,
2021
Cash equivalents$17,150 $4,397 $— $21,547 
Short-term investments
Available-for-sale securities — certificates of deposits— 255 — 255 
Available-for-sale securities — corporate bonds and notes— 186,107 — 186,107 
Available-for-sale securities — municipal bonds and notes— 13,566 — 13,566 
Available-for-sale securities — U.S. government securities— 102,615 — 102,615 
Available-for-sale securities — U.S. government agency securities
— 27,087 — 27,087 
Long-term investments
Available-for-sale securities — corporate bonds and notes— 53,107 — 53,107 
Available-for-sale securities — municipal bonds and notes— 11,111 — 11,111 
Available-for-sale securities — U.S. government securities— 59,608 — 59,608 
Available-for-sale securities — U.S. government agency securities
— 8,952 — 8,952 
Total$17,150 $466,805 $— $483,955 
The Company uses the fair value hierarchy for financial assets and liabilities. The carrying amounts of other current financial assets and other current financial liabilities approximate fair value due to their short-term nature.
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
The Company's non-financial assets and liabilities, which include goodwill, intangible assets, and long-lived assets, are not required to be carried at fair value on a recurring basis. These non-financial assets and liabilities are measured at fair value on a non-recurring basis when there is an indicator of impairment, and they are recorded at fair value only when impairment is recognized. The Company reviews goodwill for impairment annually, during the second quarter of each fiscal year, or as circumstances indicate the possibility of impairment. The Company monitors the carrying value of tangible and intangible long-lived assets for impairment whenever events or changes in circumstances indicate its carrying amount may not be recoverable. Included in the Company’s impairment considerations for non-financial assets and liabilities in the current quarter were the potential impacts of the COVID-19 pandemic.
As a result of a planned change in the use of the asset, the Company recorded an impairment of $6.2 million against the Shape trade name intangible asset, which was reflected in the Sales and Marketing line item on the Company's consolidated income statement for the three months ended December 31, 2021. The Company did not recognize any impairment charges related to its intangible assets in the first quarter of fiscal 2021.
In the first quarter of fiscal 2021, the Company recorded an impairment of $6.7 million against the operating lease right-of-use asset related to the integration of the former Shape headquarters in Santa Clara, California. Impairment charges for the first quarter of fiscal 2021 also included $0.2 million for other fixed assets associated with the Shape headquarters in Santa Clara, California. The Company calculated the fair value of the right-of-use assets, tenant improvements and other fixed assets based on estimated future discounted cash flows and classified the fair value as a Level 3 measurement due to the significance of unobservable inputs, which included the amount and timing of estimated sublease rental receipts that the Company could reasonably obtain over the remaining lease term and the discount rate. The impairment charges for the three months ended December 31, 2020 were allocated to various expense line items on the Company’s consolidated income statements based on the teams that previously worked out of the exited space.
Impairment charges were allocated to the following income statement line items for the three months ended December 31, 2021 and 2020 (in thousands):
 Three months ended
December 31,
 20212020
Cost of net product revenue$— $1,968 
Cost of net service revenue— 1 
Sales and marketing6,175 1,259 
Research and development— 3,129 
General and administrative— 516 
Total impairment charges$6,175 $6,873 
During the three months ended December 31, 2021 and 2020, the Company did not recognize any impairment charges related to goodwill.